Leadsynbio (Suzhou Leadsynbio Technology) is a synthetic-biology company that develops proprietary biosynthesis routes and manufactures pharmaceutical ingredients and nutrition products at industrial scale. Its portfolio covers active pharmaceutical ingredients and intermediates such as florfenicol, human-nutrition ingredients including NMN, NAD and 25-hydroxyvitamin D3, and animal-nutrition products, with GMP bio-manufacturing plants in Hunan and Anhui plus R&D centers in Suzhou and the US. Headquartered in Suzhou Industrial Park, the company sells to customers across global markets.
1
Round
1
Industry
4
Tags
Sep 30, 2026
Latest raise
Funding activity · 1 round
Sep 30, 2026
CNY 450M
Series C+
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
